EV Based Platform for Monitoring Therapeutics Response During Pregnancy (ARISE)

This study uses a new blood test that measures tiny particles called extracellular vesicles (EVs) to predict and monitor high blood pressure disorders during pregnancy, such as preeclampsia. The goal is to develop a better early-warning tool for pregnant people at risk. **You may be eligible if...** - You are pregnant and at least 18 years old - You are enrolled before 17 weeks of pregnancy - You are carrying a single baby - You have at least one high-risk factor for preeclampsia (such as a prior preeclamptic pregnancy, chronic high blood pressure, kidney disease, or an autoimmune condition), OR you have two moderate-risk factors (such as being a first-time mom, being over 35, being overweight, or having a multiple-pregnancy history) **You may NOT be eligible if...** - You are carrying twins or more - You are under 18 - You do not have risk factors for pregnancy-related blood pressure problems Talk to your doctor to see if this trial is right for you.